Literature DB >> 22465008

How do tumor stem cells actively escape from host immunosurveillance?

Yao Qi1, Run-Mei Li, Fan-Ming Kong, Hui Li, Jin-Pu Yu, Xiu-Bao Ren.   

Abstract

Tumor stem cells (TSCs) are considered as the "seeds" in tumor development, metastasis and recurrence. Despite the various immunosurveillance mechanisms in the host, TSCs may possess the phenotypic and functional properties to evade host immunosurveillance and immune-mediated rejection in immunologically intact individuals. The mechanisms of TSC recognition and their consequent destruction are actively disturbed by various processes, including altered immunogenicity of TSCs, production of TSC-derived regulatory molecules, and interaction of TSCs with tumor-infiltrating immune cells. In addition to these TSC-mediated mechanisms, the diverse mesenchymal cells and cytokines in the tumor microenvironment are contribute to TSC immune escape. Recent mechanistic studies provide a more comprehensive understanding of TSCs in the biology, prevention, and therapy of solid tumors. This review will focus on the latest findings for mechanisms underlying TSCs' escape from the attack of immune system.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22465008     DOI: 10.1016/j.bbrc.2012.03.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  RANK-mediated signaling network and cancer metastasis.

Authors:  Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

2.  Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.

Authors:  Yuan Jiang; Jinlu Dai; Honglai Zhang; Joe L Sottnik; Jill M Keller; Katherine J Escott; Hitesh J Sanganee; Zhi Yao; Laurie K McCauley; Evan T Keller
Journal:  Mol Cancer Res       Date:  2013-10-02       Impact factor: 5.852

3.  Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs.

Authors:  Quanfu Mao; Sharon Chu; Sailaja Ghanta; James F Padbury; Monique E De Paepe
Journal:  Respir Res       Date:  2013-03-23

Review 4.  Nanotechnology-enhanced immunotherapy for metastatic cancer.

Authors:  Peisen Zhang; Junli Meng; Yingying Li; Chen Yang; Yi Hou; Wen Tang; Kevin J McHugh; Lihong Jing
Journal:  Innovation (Camb)       Date:  2021-10-14

Review 5.  The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.

Authors:  Daniel J Silver; Maksim Sinyuk; Michael A Vogelbaum; Manmeet S Ahluwalia; Justin D Lathia
Journal:  Neuro Oncol       Date:  2015-08-11       Impact factor: 13.029

6.  Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma.

Authors:  Miao-Fen Chen; Ming-Shao Tsai; Wen-Cheng Chen; Ping-Tsung Chen
Journal:  J Clin Med       Date:  2018-09-20       Impact factor: 4.241

Review 7.  Advancement in Cancer Stem Cell Biology and Precision Medicine-Review Article Head and Neck Cancer Stem Cell Plasticity and the Tumor Microenvironment.

Authors:  Molly E Heft Neal; J Chad Brenner; Mark E P Prince; Steven B Chinn
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.